Health and Lifestyle
Nigeria’s Economic Insecurities Threaten Public Health: Emerging Evidence Suggests Folic Acid Could Play a Role in Managing Hypertension -By Daniel Nduka Okonkwo
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Readers should always consult a qualified healthcare professional regarding diagnosis, treatment, or supplementation for hypertension or any other medical condition.
Rising unemployment, inflation, and unaffordable healthcare increase stress and worsen chronic illnesses. Insecurity, violence, insurgency, and displacement further disrupt access to hospitals, nutrition, and mental health stability. Weak governance, corruption, and disrupted health programs undermine healthcare delivery and erode public trust. Together, these factors reinforce one another, leading to collapsing health systems, worsening outcomes for vulnerable groups, and stalled national development.
In essence, Nigeria’s health crisis is not only medical but deeply tied to governance, security, and economic conditions. Without stability and effective leadership, healthcare improvements alone cannot solve the problem.
Hypertension in Nigeria is a growing concern
High blood pressure, or hypertension, continues to pose a significant public health challenge in Nigeria. Estimates suggest that between 28% and 38.1% of Nigerian adults live with hypertension, translating to over 27 million individuals affected as of 2020. Recent data indicate that prevalence is rising, particularly among young, urban residents, underscoring the urgent need for preventive strategies and effective interventions.
Folic Acid and Cardiovascular Health
Medical research increasingly points to the potential protective benefits of folic acid supplementation for adults with high blood pressure. Folic acid, a B vitamin, has long been recognized for its role in preventing hypertensive disorders in pregnancy, notably pre-eclampsia. Emerging studies now suggest it may also support cardiovascular health in the general population.
A comprehensive meta-analysis of twelve randomized controlled trials published between 1970 and 2007 evaluated the impact of high-dose folic acid supplementation (≥5000 μg/day for 2–16 weeks) on blood pressure and endothelial function in hypertensive individuals. The analysis revealed modest reductions in systolic blood pressure (−2.03 mm Hg; 95% CI, −3.63 to −0.43; P = .04) but no significant change in diastolic pressure (0.01 mm Hg; 95% CI, −1.12 to 1.13). More importantly, supplementation led to a significant improvement in endothelial function, measured through flow-mediated dilation (1.61%; 95% CI, 1.27–1.96; P < .001), a key predictor of cardiovascular disease risk.
Why Endothelial Function Matters
Endothelial dysfunction plays a central role in the development of coronary heart disease. Flow-mediated dilation (FMD), a noninvasive test involving temporary occlusion of the brachial artery followed by reactive hyperemia, serves as a reliable marker of vascular health. Studies demonstrate that high-dose folic acid supplementation can enhance FMD, thereby improving endothelial function and potentially reducing long-term cardiovascular risk. Low-dose supplementation (400–800 μg/day), however, has yielded inconsistent results, highlighting the importance of appropriate dosing.
The meta-analysis included studies that met strict criteria: hypertensive adults with systolic BP above 130 mm Hg, randomized allocation to treatment or placebo groups, oral folic acid doses of at least 5000 μg/day, and interventions lasting 2–16 weeks. Trials were excluded if they involved co-intervention with other therapies, non-hypertensive populations, insufficient dosing, or inadequate reporting of outcomes.
Nigeria’s Preventive Healthcare Challenge
In Nigeria, the monthly cost of accessing modern research and supplementation guidance ranges from approximately ₦11,000 to ₦50,000, reflecting both the financial and logistical barriers to preventive healthcare. Nonetheless, ensuring adequate folate intake, through diet or supplementation, emerges as a potentially cost-effective measure to reduce stroke risk and improve vascular health among adults with high blood pressure.
Medical experts emphasize that folic acid is most clinically beneficial for improving endothelial function, which may have far-reaching effects in preventing cardiovascular events, even if reductions in blood pressure are modest. Harvard researchers note that folic acid’s role in brain and heart health underscores its importance as part of a comprehensive strategy to protect against stroke and other hypertensive complications.
High blood pressure remains a growing health concern in Nigeria, with millions affected and younger populations increasingly at risk. While folic acid supplementation may not drastically lower blood pressure, its positive effects on endothelial function highlight a promising avenue for cardiovascular protection. Adults with hypertension should discuss folate intake with qualified healthcare providers to tailor supplementation safely and effectively.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Readers should always consult a qualified healthcare professional regarding diagnosis, treatment, or supplementation for hypertension or any other medical condition.
About the Author:
Daniel Nduka Okonkwo is a Nigerian investigative journalist, publisher of Profiles International, human rights advocate, and policy analyst whose work exposes corruption, institutional failures, and the quiet forces shaping governance and global influence. With over a thousand published pieces featured on Sahara Reporters, African Defence Forum, Daily Intel Newspapers, Opinion Nigeria, African Angle, and other leading international media platforms, he blends meticulous research with compelling storytelling to drive accountability and reform. A human rights advocate, ghostwriter, and strategic communicator, Daniel transforms complex issues into clear, actionable insights that resonate both locally and globally.
Email: dan.okonkwo.73@gmail.com
